-+ 0.00%
-+ 0.00%
-+ 0.00%

Tennor Therapeutics Board Approves H-Share Buyback of Up to RMB 50 Million

PUBT·10/26/2026 09:07:11
Tennor Therapeutics Board Approves H-Share Buyback of Up to RMB 50 Million
  • Tennor Therapeutics (Suzhou)'s board authorized an H Share repurchase plan, announced October 26, 2026, capped at RMB 50 million.
  • Shareholders granted the repurchase mandate on October 23, 2026, covering up to 5,232,892 H Shares, or 10% of issued H Shares.
  • Open-market repurchases will use internal resources, with purchases dependent on market conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tennor Therapeutics (Suzhou) Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261026-12382929), on October 26, 2026, and is solely responsible for the information contained therein.